Category :

LG'S TRANSPARENT OLED TVS BECOMES THE DIGITAL CANVAS FOR KOREA'S MASTER OF INK ABSTRACTION AT FRIEZE SEOUL 2024

Frieze Seoul 2024 exhibition reunitesSuh Se Ok,the late pioneer of Korean ink abstraction,with his sons for a unique collaboration.

SoftwareSep 4, 2024

Veeva Vault CRM Suite to Unlock Greater Customer Centricity with Launch of Service Center

Expanded suite to unify sales,marketing,medical and service through a connected software and data foundation

SoftwareSep 4, 2024

The 9th Anniversary Gala of 17sing came to perfect end - Music is everywhere

TAIPEI,Sept. 4,2024-- In summer time,17sing,Taiwan\'s most popular karaoke social app,celebrates its ninth anniversary and has launched an anniversary event that lasts for more than a month. Tens of m

Big DataSep 4, 2024

Innovent Receives Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α Bispecific Antibody Fusion Protein) as Monotherapy for Advanced Melanoma

SAN FRANCISCOand SUZHOU,China,Sept. 4,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qua

SpaceSep 4, 2024

Axcelis Announces Sponsorship and Participation in The International Conference on Ion Implantation Technology 2024 in Toyoma, Japan

BEVERLY,Mass.,Sept. 4,2024-- Axcelis Technologies,Inc. (NASDAQ: ACLS),a leading supplier of enabling ion implantation solutions for the semiconductor industry,will be a top-level Platinum Sponsor at

SpaceSep 4, 2024

CNOOC Limited Brings On-stream Wushi 17-2 Oilfields

HONG KONG,Sept. 4,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) announces today that Wushi 17-2 Oilfields Development Project has commen

AISep 4, 2024

IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances

MELBOURNE,Australia,Sept. 4,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces that the Company\'s IPAX-1 Phase I study has been published in Neuro-Oncology Advances,co

SoftwareSep 4, 2024

Nature's Miracle Announces Participation in the H.C. Wainwright Annual Global Investment Conference

ONTARIO,Calif.,Sept. 4,2024-- Nature\'s Miracle Holding Inc. (NASDAQ: NMHI) ("Nature\'s Miracle" or the "Company"),a leader in vertical farming technology and infrastructure,today

BiologySep 4, 2024

AV-Comparatives Identifies Key Cybersecurity Threats for Summer 2024: Fakeshops, Phishing Attacks and Targeting Children

Unveiling the Rise of Counterfeit Retail Platforms,SophisticatedPhishing Schemes,and Increasing Cyber Risks for Minors in Summer 2024

AISep 4, 2024

Acepodia Enters Strategic Clinical Collaboration with Pfizer to Accelerate Development of Antibody-Cell Conjugation-Based Cell Therapies in Autoimmune Diseases

Through Pfizer Ignite,Acepodia will gain access to Pfizer\'s resources,scale and expertise as the company broadens the application of its platform beyond oncology into autoimmune diseases

EnergySep 4, 2024
Your premier source for cutting-edge news in the realms of technology, artificial intelligence, energy, and more. Explore the future of tech with Arinstar! Stay informed, stay inspired!

Quick Search

Explore our curated content, stay informed about groundbreaking innovations, and journey into the future of science and tech.

© ArinstarTechnology

Privacy Policy